Volume : VII, Issue : IV, April - 2018

SAFETY AND EFICACY OF INTRAVITREAL TRIAMCINOLONE IN PANUVEITIS

Dr Prof Pushpa Varma, Dr Shweta Walia

Abstract :

Uveitis is inflammation of uveal tract and mainly affects young people . It has a worldwide prevalence ranging from 38 to 730 per 100 000. If not properly managed it can cause many  devastating sight–threatening complications . The goals of therapy for uveitis are to reduce inflammation, prevent damage to ocular structures, and prevent long–term visual loss. In panuveitis all components of uvea are inlammed .To contrl inflammation in posterior segment topical therapy is not sufficient and systemic therapy with steroids has many sideeffects. Triamcinolone acetonide is a potent corticosteroid and can be administered by intravitreal route. Higher concentration is achieved at the site of inflammation The purpose of this study is to evaluate the role ofintravitreal triamcinolone in improving visual acuity and clinical features of patients with treatment resistant panuveitis.

Article: Download PDF    DOI : https://www.doi.org/10.36106/paripex  

Cite This Article:

Dr (Prof ) Pushpa Varma, Dr Shweta Walia, SAFETY AND EFICACY OF INTRAVITREAL TRIAMCINOLONE IN PANUVEITIS, PARIPEX‾INDIAN JOURNAL OF RESEARCH : Volume-7 | Issue-4 | April-2018

Number of Downloads : 152

References :